Somatostatin Receptor Scintigraphy for Bronchial Carcinoid Follow-Up

Stefano Fanti, Mohsen Farsad, Giuseppe Battista, Francesco Monetti, Gian Carlo Montini, Arturo Chiti, Giordano Savelli, Francesco Petrella, Alessandro Bini, Cristina Nanni, Annadina Romeo, Roberto Franchi, Emilio Bombardieri, Romeo Canini, Nino Monetti

Research output: Contribution to journalArticlepeer-review


Purpose: Somatostatin receptor scintigraphy (SRS) has been used to diagnose bronchial carcinoids (BC) and is a valuable tool for accurate staging of BC. The aim of this study was to evaluate the role of SRS in restaging BC and following patients after treatment. Methods: Thirty-one patients (18 male, 13 female) with confirmed BC who were referred during the last 7 years were included. Patients were examined via chest radiograph (12 studies), chest or abdominal computed tomography (CT; 28 scans), chest magnetic resonance imaging (2 scans), and liver ultrasound (5 scans). Results: Overall, in 22 patients (71%), SRS confirmed the data obtained by other diagnostic procedures (16 negative and 6 positive findings). In 6 patients, SRS showed focal lesions not previously demonstrated. In 2 patients, SRS resolved uncertain findings of CT. In 1 patient, SRS showed fewer lesions compared with CT. In 8 of 31 patients, important diagnostic information obtained by SRS was not revealed by any other imaging procedure. Conclusion: Our results indicate that SRS is a reliable, noninvasive method that could be considered the principal follow-up procedure in patients with BC.

Original languageEnglish
Pages (from-to)548-552
Number of pages5
JournalClinical Nuclear Medicine
Issue number7
Publication statusPublished - Jul 2003


  • Bronchial Carcinoid
  • Somatostatin Receptor Scintigraphy

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology


Dive into the research topics of 'Somatostatin Receptor Scintigraphy for Bronchial Carcinoid Follow-Up'. Together they form a unique fingerprint.

Cite this